Boehringer Ingelheim's R&D expenditure as revenue share 2025

Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2025

Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2025

Last update:

Jul 10, 2026

Author:

��ƽ�� Research Department

Regions:

Worldwide, Germany

Survey time period:

From 01/01/2004 to 31/12/2025

In 2025, about percent of the company's total revenues were spent on research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2025

Get in touch with us for additional information

��ƽ��